ID

26112

Description

Study ID: 101468/219 Clinical Study ID: 101468/219 Study Title:An open label, randomised, five-way crossover single-dose pharmacokinetic study to assess dosage strength equivalence of ropinirole CR in healthy male and female volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Parkinson Disease Documentation part: Serious Adverse Event

Keywords

Versions (1)
  1. 10/9/17 10/9/17 -
Copyright Holder

GlaxoSmithKline

Uploaded on

October 9, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

No comments

In order to download data models you must be logged in. Please log in or register for free.

Dose strength equivalence of ropinirole CR in healthy adults Serious Adverse Event 101468/219

English

Serious Adverse Event Dose strength equivalence of ropinirole CR in healthy adults 101468/219

1 forms  
Serious Adverse Event
Description

Serious Adverse Event

Alias
UMLS CUI-1
C1519255
Patient Number
Description

Patient Number

Data type

integer

Alias
UMLS CUI [1]
C2348585
Center Number
Description

Center Number

Data type

integer

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0600091
Visit Date
Description

Visit Date

Data type

date

Alias
UMLS CUI [1]
C1320303
Person Reporting SAE
Description

Person Reporting SAE

Data type

text

Alias
UMLS CUI [1,1]
C0008961
UMLS CUI [1,2]
C1519255
Serious Adverse Event
Description

Serious Adverse Event

Data type

boolean

Alias
UMLS CUI [1]
C1519255
Serious Adverse Event
Description

Specify reason(s) for considering this a serious AE. Mark all that apply.

Data type

text

Alias
UMLS CUI [1]
C1519255
Serious Adverse Event
Description

Specify reason(s) for considering this a serious AE. If Other, please specify.

Data type

text

Alias
UMLS CUI [1]
C1519255
Outcome
Description

*If subject died, please inform GSK within 24 hours and complete Form D

Data type

integer

Alias
UMLS CUI [1,1]
C1705586
UMLS CUI [1,2]
C1519255
Adverse Event Onset Date
Description

Adverse Event Onset Date

Data type

date

Alias
UMLS CUI [1,1]
C2985916
UMLS CUI [1,2]
C1519255
Adverse Event Onset Time
Description

Adverse Event Onset Time

Data type

time

Alias
UMLS CUI [1,1]
C2697889
UMLS CUI [1,2]
C1519255
Adverse Event End Date
Description

Adverse Event End Date

Data type

date

Alias
UMLS CUI [1,1]
C2697886
UMLS CUI [1,2]
C1519255
Adverse event end time
Description

Adverse event end time

Data type

time

Alias
UMLS CUI [1,1]
C2826658
UMLS CUI [1,2]
C1519255
Event Course
Description

adverse event course

Data type

integer

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0750729
Number of episodes
Description

If Intermittent = "Yes"

Data type

integer

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C4086638
Intensity (maximum)
Description

Intensity of the adverse event

Data type

integer

Alias
UMLS CUI [1,1]
C1710066
UMLS CUI [1,2]
C1519255
Action Taken with Respect to lnvestigational Drug
Description

Action Taken in response to event

Data type

integer

Alias
UMLS CUI [1,1]
C1547656
UMLS CUI [1,2]
C0304229
UMLS CUI [2]
C1519255
Relationship to lnvestigational Drug
Description

Relationship to lnvestigational Drug

Data type

integer

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0439849
UMLS CUI [1,3]
C0304229
Corrective Therapy
Description

Corrective Therapy. If "Yes", Please record on Concomitant Medication form

Data type

boolean

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0087111
Was subject withdrawn due to this AE?
Description

withdrawn due to event

Data type

boolean

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C1519255
Did the SAE abate?
Description

SAE abate

Data type

boolean

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0547047
Was study medication reintroduced (or dose increased)?
Description

If study medication was interrupted, stopped or dose reduced: Was study medication reintroduced (or dose increased)?

Data type

boolean

Alias
UMLS CUI [1]
C0304229
UMLS CUI [2]
C1519255
If yes, did SAE recur?
Description

If study medication was interrupted, stopped or dose reduced: Was study medication reintroduced (or dose increased)?

Data type

boolean

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0034897
Is the SAE is probably associated with: Protocol design or procedures (but not to study drug)
Description

SAE associated with protocol procedures

Data type

boolean

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0439849
UMLS CUI [1,3]
C0087111
If Yes, please specify
Description

Is the SAE is probably associated with: Protocol design or procedures (but not to study drug)

Data type

text

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0439849
UMLS CUI [1,3]
C0087111
Is the SAE is probably associated with: Another condition (eg, condition under study, intercurrent illness)
Description

SAE associated with other condition

Data type

boolean

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0439849
UMLS CUI [1,3]
C0012634
If Yes, please specify
Description

Is the SAE is probably associated with: Another condition (eg, condition under study, intercurrent illness)

Data type

text

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0439849
UMLS CUI [1,3]
C0012634
Is the SAE is probably associated with: Another drug
Description

SAE associated with other drug

Data type

boolean

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0439849
UMLS CUI [1,3]
C0013227
If Yes, please specify
Description

Is the SAE is probably associated with: Another drug

Data type

text

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0439849
UMLS CUI [1,3]
C0013227
Remarks
Description

(Please provide a brief narrative description of the SAE, attaching extra pages eg. hospital discharge summary if necessary)

Data type

text

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0947611
Relevant Laboratory Data
Description

Relevant Laboratory Data

Alias
UMLS CUI-1
C0587081
UMLS CUI-2
C1519255
Test
Description

Test

Data type

text

Alias
UMLS CUI [1]
C0022885
Date
Description

Date

Data type

date

Alias
UMLS CUI [1,1]
C0022885
UMLS CUI [1,2]
C0011008
Value
Description

Value

Data type

text

Alias
UMLS CUI [1]
C0587081
Units
Description

Units

Data type

text

Alias
UMLS CUI [1]
C1519795
Normal Range
Description

Normal Range

Data type

text

Alias
UMLS CUI [1,1]
C0086715
UMLS CUI [1,2]
C0587081
Back to the top of the page

Similar models

Serious Adverse Event Dose strength equivalence of ropinirole CR in healthy adults 101468/219

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Serious Adverse Event
C1519255 (UMLS CUI-1)
Patient Number
Item
Patient Number
integer
C2348585 (UMLS CUI [1])
Center Number
Item
Center Number
integer
C1301943 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Visit Date
Item
Visit Date
date
C1320303 (UMLS CUI [1])
Person Reporting SAE
Item
Person Reporting SAE
text
C0008961 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Serious Adverse Event
Item
Serious Adverse Event
boolean
C1519255 (UMLS CUI [1])
Item
Serious Adverse Event
text
C1519255 (UMLS CUI [1])
Serious Adverse Event
Code List
Serious Adverse Event
CL Item
results in Death (A)
CL Item
life threatening (B)
CL Item
requires hospitalisation or prolongationof existing hospitalization (C)
CL Item
results in disability/incapacity (D)
CL Item
congenital anomaly/birth defect (E)
CL Item
other (see definition) (F)
Serious Adverse Event
Item
Serious Adverse Event
text
C1519255 (UMLS CUI [1])
Item
Outcome
integer
C1705586 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Adverse event outcome
Code List
Outcome
CL Item
Resolved (1)
CL Item
Ongoing (2)
CL Item
Died (3)
Adverse Event Onset Date
Item
Adverse Event Onset Date
date
C2985916 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Adverse Event Onset Time
Item
Adverse Event Onset Time
time
C2697889 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Adverse Event End Date
Item
Adverse Event End Date
date
C2697886 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Adverse event end time
Item
Adverse event end time
time
C2826658 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Item
Event Course
integer
C1519255 (UMLS CUI [1,1])
C0750729 (UMLS CUI [1,2])
adverse event course
Code List
Event Course
CL Item
Intermittent (1)
CL Item
Constant (2)
adverse event number of episodes
Item
Number of episodes
integer
C1519255 (UMLS CUI [1,1])
C4086638 (UMLS CUI [1,2])
Item
Intensity (maximum)
integer
C1710066 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Intensity of the adverse event
Code List
Intensity (maximum)
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
Item
Action Taken with Respect to lnvestigational Drug
integer
C1547656 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C1519255 (UMLS CUI [2])
Action Taken in response to event
Code List
Action Taken with Respect to lnvestigational Drug
CL Item
None (1)
CL Item
Dose reduced (2)
CL Item
Dose increased (3)
CL Item
Drug interrupted/restarted (4)
CL Item
Drug stopped (5)
Item
Relationship to lnvestigational Drug
integer
C1519255 (UMLS CUI [1,1])
C0439849 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
Relationship to lnvestigational Drug
Code List
Relationship to lnvestigational Drug
CL Item
Related (1)
CL Item
Possibly related (2)
CL Item
Probably unrelated  (3)
CL Item
Unrelated (4)
corrective therapy
Item
Corrective Therapy
boolean
C1519255 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
withdrawn due to event
Item
Was subject withdrawn due to this AE?
boolean
C0422727 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
SAE abate
Item
Did the SAE abate?
boolean
C1519255 (UMLS CUI [1,1])
C0547047 (UMLS CUI [1,2])
study medication reintroduced
Item
Was study medication reintroduced (or dose increased)?
boolean
C0304229 (UMLS CUI [1])
C1519255 (UMLS CUI [2])
SAE recur
Item
If yes, did SAE recur?
boolean
C1519255 (UMLS CUI [1,1])
C0034897 (UMLS CUI [1,2])
SAE associated with protocol procedures
Item
Is the SAE is probably associated with: Protocol design or procedures (but not to study drug)
boolean
C1519255 (UMLS CUI [1,1])
C0439849 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
SAE associated with protocol procedures
Item
If Yes, please specify
text
C1519255 (UMLS CUI [1,1])
C0439849 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
SAE associated with other condition
Item
Is the SAE is probably associated with: Another condition (eg, condition under study, intercurrent illness)
boolean
C1519255 (UMLS CUI [1,1])
C0439849 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,3])
SAE associated with other condition
Item
If Yes, please specify
text
C1519255 (UMLS CUI [1,1])
C0439849 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,3])
SAE associated with other drug
Item
Is the SAE is probably associated with: Another drug
boolean
C1519255 (UMLS CUI [1,1])
C0439849 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
SAE associated with other drug
Item
If Yes, please specify
text
C1519255 (UMLS CUI [1,1])
C0439849 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
Remarks
Item
Remarks
text
C1519255 (UMLS CUI [1,1])
C0947611 (UMLS CUI [1,2])
Item Group
Relevant Laboratory Data
C0587081 (UMLS CUI-1)
C1519255 (UMLS CUI-2)
Test
Item
Test
text
C0022885 (UMLS CUI [1])
Date
Item
Date
date
C0022885 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Value
Item
Value
text
C0587081 (UMLS CUI [1])
Units
Item
Units
text
C1519795 (UMLS CUI [1])
Normal Range
Item
Normal Range
text
C0086715 (UMLS CUI [1,1])
C0587081 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial